BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 9180905)

  • 1. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
    Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
    J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
    Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
    J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological importance of the 1,25(OH)2D3 membrane receptor and evidence for a membrane receptor specific for 24,25(OH)2D3.
    Pedrozo HA; Schwartz Z; Rimes S; Sylvia VL; Nemere I; Posner GH; Dean DD; Boyan BD
    J Bone Miner Res; 1999 Jun; 14(6):856-67. PubMed ID: 10352093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures.
    Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD
    J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C.
    Schmitz JP; Schwartz Z; Sylvia VL; Dean DD; Calderon F; Boyan BD
    J Cell Physiol; 1996 Sep; 168(3):570-9. PubMed ID: 8816911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms.
    Boyan BD; Dean DD; Sylvia VL; Schwartz Z
    Connect Tissue Res; 2003; 44 Suppl 1():130-5. PubMed ID: 12952186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C.
    Nemere I; Schwartz Z; Pedrozo H; Sylvia VL; Dean DD; Boyan BD
    J Bone Miner Res; 1998 Sep; 13(9):1353-9. PubMed ID: 9738506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma membrane requirements for 1alpha,25(OH)2D3 dependent PKC signaling in chondrocytes and osteoblasts.
    Boyan BD; Wang L; Wong KL; Jo H; Schwartz Z
    Steroids; 2006 Apr; 71(4):286-90. PubMed ID: 16325216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice.
    Boyan BD; Sylvia VL; McKinney N; Schwartz Z
    J Cell Biochem; 2003 Dec; 90(6):1207-23. PubMed ID: 14635194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone cartilage cells in vitro.
    Schwartz Z; Schlader DL; Ramirez V; Kennedy MB; Boyan BD
    J Bone Miner Res; 1989 Apr; 4(2):199-207. PubMed ID: 2786322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of prostaglandin E(2) receptors and their role in 24,25-(OH)(2)D(3)-mediated effects on resting zone chondrocytes.
    Del Toro F; Sylvia VL; Schubkegel SR; Campos R; Dean DD; Boyan BD; Schwartz Z
    J Cell Physiol; 2000 Feb; 182(2):196-208. PubMed ID: 10623883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes.
    Pedrozo HA; Schwartz Z; Mokeyev T; Ornoy A; Xin-Sheng W; Bonewald LF; Dean DD; Boyan BD
    J Cell Biochem; 1999 Jan; 72(1):151-65. PubMed ID: 10025676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17beta-estradiol regulation of protein kinase C activity in chondrocytes is sex-dependent and involves nongenomic mechanisms.
    Sylvia VL; Hughes T; Dean DD; Boyan BD; Schwartz Z
    J Cell Physiol; 1998 Aug; 176(2):435-44. PubMed ID: 9648931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nongenomic regulation of extracellular matrix events by vitamin D metabolites.
    Boyan BD; Dean DD; Sylvia VL; Schwartz Z
    J Cell Biochem; 1994 Nov; 56(3):331-9. PubMed ID: 7876326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
    Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R
    J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonic acid directly mediates the rapid effects of 24,25-dihydroxyvitamin D3 via protein kinase C and indirectly through prostaglandin production in resting zone chondrocytes.
    Schwartz Z; Sylvia VL; Curry D; Luna MH; Dean DD; Boyan BD
    Endocrinology; 1999 Jul; 140(7):2991-3002. PubMed ID: 10385391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of protein kinase C by transforming growth factor beta 1 in rat costochondral chondrocyte cultures.
    Sylvia VL; Mackey S; Schwartz Z; Schuman L; Gomez R; Boyan BD
    J Bone Miner Res; 1994 Sep; 9(9):1477-87. PubMed ID: 7817833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes.
    Schwartz Z; Dean DD; Walton JK; Brooks BP; Boyan BD
    Endocrinology; 1995 Feb; 136(2):402-11. PubMed ID: 7530645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha,25-dihydroxyvitamin D(3) and 24R,25-dihydroxyvitamin D(3) modulate growth plate chondrocyte physiology via protein kinase C-dependent phosphorylation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase.
    Schwartz Z; Ehland H; Sylvia VL; Larsson D; Hardin RR; Bingham V; Lopez D; Dean DD; Boyan BD
    Endocrinology; 2002 Jul; 143(7):2775-86. PubMed ID: 12072413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.